Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115660) titled 'Efficacy and Safety of Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated with Meibomian Gland Dysfunction in Patients with Type 2 Diabetes: A Randomized, Controlled Clinical Trial' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Qingdao Eye Hospital of Shandong First Medical University
Condition:
Type 2 Diabetes Mellitus Complicating Meibomian Gland Dysfunction-Associated Dry Eye Disease
Intervention:
0.3% Sodium Hyaluronate Eye Drops Group:0.3% Sodium Hyaluronate Eye Drops
Perfluorohexyl Octane Eye Drops + 0.3% Sodium Hyaluronate Eye Drops Group:Perfl...